← Back to headlines
Wells Fargo Identifies AMP-007 as Key to Amphastar Pharmaceuticals' Growth
Wells Fargo analysts believe Amphastar Pharmaceuticals, Inc.'s drug AMP-007 will be crucial for achieving mid- to high-single-digit growth.
2 Mar, 15:23 — 2 Mar, 15:23
Sources
Showing 1 of 1 sources
